IBRX

NASDAQ · Biotechnology

Immunitybio Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.29

+0.84 (+9.94%)

As of Sep 22, 9:50 PM ET ·

Day Range $8.37 — $9.48

52W Range $1.95 — $12.43

Performance

1D —

1W —

1M —

3M —

6M —

1Y +258.69%

YTD +359.90%

Open$8.45

Previous Close$8.45

Day High$9.48

Day Low$8.37

52W High$12.43

52W Low$1.95

Volume—

Avg Volume9.46M

Market Cap8.63B

P/E Ratio—

EPS$-0.97

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $4.22 Above

SMA 200 $2.95 Above

RSI (14) 70.9 Overbought

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

10 analysts

9 Buy 1 Hold 0 Sell

Price Target +1,071.0% upside

Current
$9.29

Target
$108.79

$71.54 $108.79 avg $142.95

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	125.34M	1.55B	1.61B
Net Income	-388,624,952	174.18M	206.87M
Profit Margin	-310.2%	11.2%	12.9%
EBITDA	-266,035,143	310.76M	319.11M
Free Cash Flow	—	125.72M	219.44M
Rev Growth	+678.6%	+14.4%	+15.1%
Debt/Equity	0.01	0.68	0.80

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$265.21	+0.28%	74.0	466.74B
AMGN	Amgen Inc	$410.24	+4.34%	23.7	207.25B
GILD	Gilead Sciences Inc	$152.67	+1.40%	—	187.10B
VRTX	Vertex Pharmaceuticals Inc	$514.99	+0.84%	29.7	130.64B
REGN	Regeneron Pharmaceuticals	$803.90	+0.72%	18.6	80.58B
ALNY	Alnylam Pharmaceuticals Inc	$251.65	+3.00%	40.0	32.33B